Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial | BMC Cancer | Full Text

Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial | BMC Cancer | Full Text

Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial

Cancer-related fatigue (CRF) is one of the most prevalent complications experienced by cancer patients during and after the process of treatment. Despite conducting a lot of studies, there is no approved thera...

Authors:Ebrahim Salehifar, Saeid Azimi, Ghasem Janbabai, Ehsan Zaboli, Narjes Hendouei, Fatemeh Saghafi and Samaneh Borhani

Citation:BMC Cancer 2020 20:158

Content type:Research article

Published on: 27 February 2020

• ViewFull Text
 
• ViewPDF